In a major step forward for cancer treatment, researchers have developed a new type of “smart” chemical that attacks ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ ...

Using our nano-lipid delivery system, we injected the drug directly into the tumor in a tumor model and successfully took out the gene - literally cutting it out from the cancer cell's DNA with th ...

Telomir-1 reduced tumor size by 50% in a prostate cancer model and protected against chemotherapy ... tumor development…We are seeing a drug that extends cellular health while simultaneously ...

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

Contrary to concerns that telomere-elongating drugs may promote cancer, Telomir-1 demonstrated the opposite effect—actively suppressing tumor development, while selectively benefiting healthy cells.

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

The model harnesses whole-slide tumor imaging data and gene ... “Perhaps an abundance of fibroblasts can shield tumor cells from chemotherapeutic drugs or support cancer cell growth. I would like to ...

This model allows the tumor to spontaneously evolve after implantation, making it possible to discern the drug's impact on the surrounding tumor microenvironment. The research team found that RAS ...

New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.